Catasys Inc. Common Stock (PK:CATS)
Business Focus: N/A
Jul 06, 2020 04:30 pm ET
Catasys, Inc. is now Ontrak, Inc.
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced that the company will adopt the name of its market-leading solution, becoming Ontrak, Inc. Effective Tuesday, July 7, 2020, the company’s common stock will trade under the ne
Jun 30, 2020 08:30 am ET
National Health Plan Expands Catasys’ OnTrak-CI Program Across Their National Medicare Advantage Business
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced a three-year contract with a leading national health plan for the accelerated expansion of its OnTrak-CI solution. This nationwide, simultaneously-launched expansion e
May 19, 2020 08:30 am ET
Catasys Employees Honor Mental Health Awareness Month by Donating to Non-Profit Organizations that Address Social Determinants of Health
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced that its more than 500 employees have chosen to fund the programs of 26 non-profit partner organizations who actively serve OnTrakTM communities to treat the whole
May 15, 2020 08:30 am ET
Catasys to Present at the RBC Capital Markets 2020 Global Healthcare Conference
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, and Mr. Curt Medeiros, the Company’s President and Chief Operating Officer, are scheduled to present at the 2020 RBC C
May 12, 2020 08:30 am ET
Catasys Expands OnTrak-A Solution with Leading National Health Plan into Arizona
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced the expansion of its OnTrak-A solution with a leading national health plan into Arizona. This expansion ensures that eligible commercial and Medicare Advantage members
May 07, 2020 04:03 pm ET
Catasys Announces 2020 First Quarter Financial Results
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), an AI and telehealth enabled, virtualized outpatient healthcare treatment company, today reported its financial results for the first quarter ended March 31, 2020. The Company provides big data-based analytics and predictive identification and engagement capabilities to health plans and their members through its OnTrak™ solution on the Catasys PRE™ (Predict-Recommend-Engage) platform.
May 04, 2020 08:30 am ET
Catasys Schedules 2020 First Quarter Financial Results Conference Call for May 7, 2020
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its first quarter ended March 31, 2020, after the closing of the stock market on Thursday, May 7, 2020.
Apr 07, 2020 08:30 am ET
Catasys Expands OnTrak-A Solution with Leading National Health Plan into Indiana, Wisconsin, Kentucky and Arkansas
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced the expansion of its OnTrak-A solution with a leading national health plan into Indiana, Wisconsin, Kentucky and Arkansas. This expansion ensures that eligible commerc
Mar 25, 2020 08:30 am ET
Catasys’ Telehealth-Enabled OnTrak™ Programs See Surge in Enrollment and Engagement Amidst COVID-19 Pandemic
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced that the Company is surpassing a weekly rate of 500 member enrollments for the month of March. The Company historically averages approximately $6,500 net revenue per enrolled
Mar 17, 2020 08:30 am ET
Brandon H. LaVerne, Chief Financial Officer of $2.2 Billion Technology Solutions Provider, PCM, Inc., Joins Catasys as Chief Financial Officer
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and telehealth enabled, virtualized outpatient healthcare treatment company, today announced the appointment of Mr. Brandon H. LaVerne as Chief Financial Officer.
Mar 12, 2020 04:05 pm ET
Catasys Announces 2019 Fourth Quarter Financial and Year-end Financial Results
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), an AI and telehealth enabled, virtualized outpatient healthcare treatment company, today reported its financial results for the fourth quarter and year ended December 31, 2019. The Company provides big data-based analytics and predictive identification and engagement capabilities to
Mar 03, 2020 08:30 am ET
Brian Kelly, President of Clinical Healthcare Solutions at Ascend Learning, Joins Catasys in New Senior Executive Vice President Role
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Brian Kelly to the newly created position of Senior Executive Vice President, Product Portfolio. Mr. Kelly will report to Mr. Curt Medeiros who joined Catasys as President and COO in Dec
Mar 02, 2020 08:30 am ET
Catasys Schedules 2019 Fourth Quarter and Year-end Financial Results Conference Call for March 12, 2020
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its fourth quarter and year ended December 31, 2019, after the closing of the stock market on Thursday, March 12, 2020.
Feb 27, 2020 08:30 am ET
Catasys Expands OnTrak-A Solution with Leading National Health Plan into Colorado, Washington, D.C., Virginia and Louisiana
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into Colorado, Washington, D.C., Virginia and Louisiana beginning March 20, 2020. This expansion ensures that eligible commercial and
Dec 17, 2019 08:30 am ET
Catasys Expands OnTrak-A Solution With Leading National Health Plan Into California
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into California beginning January 31, 2020. This expansion ensures that eligible commercial members of the health plan in California w
Dec 03, 2019 08:30 am ET
Curt Medeiros, President of OPTUM Advanced Data and Analytics at UnitedHealth Group, Joins Catasys as President and Chief Operating Officer
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Curt Medeiros as President and Chief Operating Officer.
Nov 19, 2019 08:30 am ET
Catasys Appoints Industry Executive Gus Giraldo to Board of Directors
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Gustavo Giraldo to its Board of Directors, replacing Ms. Sharon Gabrielson. The number of Board members remains at seven.
Nov 13, 2019 04:05 pm ET
Catasys Announces 2019 Third Quarter Financial Results
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today reported its financial results for the third quarter ended September 30, 2019. The Company provides big data-based analytics and predictive identification and engagement capabilities to health plans and their members through its OnTrakTM
Nov 11, 2019 08:30 am ET
Catasys Schedules 2019 Third Quarter Financial Results Conference Call for November 13, 2019
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its third quarter ended September 30, 2019, after the closing of the stock market on Wednesday, November 13, 2019.
Nov 05, 2019 08:30 am ET
Catasys to Present at Credit Suisse 28th Annual Healthcare Conference
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to present at the 28th Annual Healthcare Conference on Tuesday, November 12, 2019, at 4:10 p.m. MST. Management will also be participating in one-on-one and small group meetings that day.
Sep 24, 2019 08:30 am ET
Catasys Announces $45 Million Debt Financing Commitment from Goldman Sachs to Support Accelerating Growth
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, has entered into a financing agreement with Goldman Sachs Specialty Lending Group, L.P. (“Goldman Sachs”) involving the placement of Senior Secured Notes due 2024 pursuant to a committed purchase of up to $45 million, comprised of a $35 mil
Aug 29, 2019 08:30 am ET
Catasys to Participate in 4th Annual Dougherty & Company Institutional Investor Conference
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to participate in one-on-one and small group meetings at the 4th annual Dougherty & Company Institutional Investor Conference being held Thursday, September 5, 2019, at the Millennium Hotel in Minneapolis.
Aug 14, 2019 04:05 pm ET
Catasys Reports 2019 Second Quarter Financial Results
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today reported its financial results for the second quarter ended June 30, 2019. The Company provides big data-based analytics and predictive identification and engagement capabilities to health plans and their members through its OnTrak™ solution on the Catasys PRE™ platform.
Aug 13, 2019 08:30 am ET
Catasys Expands Partnership with Leading National Health Plan
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into six new states. OnTrak-A will serve eligible members in Ohio, Tennessee, North Carolina, South Carolina, Maryland and Delaware. It is also the f
Aug 12, 2019 08:30 am ET
Catasys Schedules 2019 Second Quarter Financial Results Conference Call for August 14, 2019
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter ended June 30, 2019, after the closing of the stock market on Wednesday, August 14, 2019.
Aug 12, 2019 06:30 am ET
BriaCell Appoints Richard J. Berman to Board of Directors
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced that it has appointed Mr. Richard J....
Jul 31, 2019 08:30 am ET
Catasys to Present at the Canaccord Genuity 39th Annual Growth Conference
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to present at the Canaccord Genuity 39th Annual Growth Conference on Wednesday, August 7, 2019, at 2 p.m. ET. Management will also be participating in one-on-one meetings at the two-day event.
Jul 23, 2019 08:30 am ET
Catasys Launches Breakthrough AI Capability to Address Chronic Disease
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced Catasys PRETM (Predict-Recommend-Engage).
Jul 18, 2019 08:30 am ET
Catasys Appoints Industry Veteran Rob Rebak to Board of Directors
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Robert L. Rebak to its Board of Directors, replacing Mr. Richard J. Berman. The number of Board members remains at seven.
Jul 01, 2019 08:30 am ET
Catasys Announces Addition to Russell 3000® and 2000® Indexes
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has been added to the Russell 3000® and 2000® Indexes, effective after the U.S. markets open on Monday, July 1, 2019, as part of the 2019 Russell U.S. Indexes reconstitution.
Jun 26, 2019 08:30 am ET
Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Daniel Prewitt as the senior vice president of sales. In this role, Prewitt will be responsible for leading the Company’s sales to health plans and self-funded employers.
Jun 10, 2019 08:30 am ET
Sharon R. Gabrielson Named Chair of Sharps Compliance Board of Directors
Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced that Sharon R. Gabrielson has...
Jun 06, 2019 08:30 am ET
Catasys Adds Canary Health to OnTrak Platform
Catasys,
Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and
technology-enabled healthcare company, today announced a strategic
partnership with digital therapeutics company
May 20, 2019 08:30 am ET
Catasys to Present at the B. Riley FBR Institutional Investor Conference on Wednesday, May 22, 2019
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that Mr.
Terren Peizer, the Company’s Chairman and Chief Executive Officer, will
present at the B. Riley FBR Institutional Investor Conference in Beverly
Hills, CA on Wednesday, May 22, 2019 at 11:00 a.m. ET (8:00 a.m. PT).
May 15, 2019 08:30 am ET
Catasys to Provide OnTrak™ Program Free to Members in Need Throughout May to Honor Mental Health Awareness Month
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that for
every day in the month of May, it is sponsoring a health plan member who
would otherwise not be able to participate in OnTrak, at no cost to
either the member or the health plan.
May 09, 2019 04:05 pm ET
Catasys Reports 2019 First Quarter Financial Results
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today reported its financial
results for the first quarter ended March 31, 2019. The Company provides
big data-based analytics and predictive modeling driven healthcare
services to health plans and their members through its OnTrak™ solution.
May 09, 2019 08:30 am ET
Catasys Announces Proprietary Interventions for Treatment of Loneliness Epidemic
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it is
expanding the use of its OnTrak solution to help identify and address
loneliness.
May 08, 2019 08:30 am ET
Catasys Announces Partnership with Circulation and Lyft
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced a strategic
partnership with Circulation, a leading manager of non-emergent medical
transportation (NEMT) programs for state government agencies, hospitals
and managed care organizations. Catasys’ OnTrak™ solution will now
incorporate transportation services provided by Lyft, Inc. (NASDAQ:
LYFT) (“Lyft”) and other specialty transportation network companies to
further address member needs relating to social determinan
May 07, 2019 08:30 am ET
Catasys Expands OnTrak-C Solution with Leading National Health Plan
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it has
expanded its OnTrak-C solution with one of the nation's leading health
insurance providers. Eligible Medicaid members in Texas will now be able
to participate in OnTrak for treatment of anxiety and depression, in
addition to substance use disorders.
May 06, 2019 08:30 am ET
Catasys Schedules 2019 First Quarter Financial Results Conference Call for May 9, 2019
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that the
Company will be releasing financial results for its first quarter ended
March 31, 2019, after the closing of the stock market on Thursday, May
9, 2019.
Apr 30, 2019 08:30 am ET
Catasys Expands OnTrak-Ci Solution with Leading National Health Plan’s Eligible Medicare Advantage Members in Alabama, Mississippi and Florida
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it has
expanded its OnTrak-Ci solution to eligible Medicare Advantage members
in Alabama, Mississippi and Florida with one of the nation’s leading
health plans. Alabama and Mississippi represent the 23rd and
24th states in which OnTrak is available to members of major
health plans.
Apr 25, 2019 08:30 am ET
Catasys to Present at ThinkEquity Conference on May 2, 2019 in New York City
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that the
Company will present at the ThinkEquity Conference on Thursday, May 2,
2019 at 2:30 pm ET at the Mandarin Oriental Hotel in New York City.
Catasys will also be conducting one-on-one meetings throughout the day.
Apr 23, 2019 08:30 am ET
Catasys Announces Agreement with Optima Health
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it has
entered into an agreement with Optima Health to provide its OnTrak
solution to eligible Commercial members in Virginia. Launch is expected
in the second quarter of 2019.
Apr 09, 2019 08:30 am ET
Catasys Appoints Healthcare Industry Leader Carol Murdock to Newly Created Chief Commercial Officer Role
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, today announced
the appointment of Carol Murdock as Chief Commercial Officer. She will
lead Business Development, Account Management, Marketing and Corporate
Communications, reporting to Mr. Terren Peizer, Chairman and CEO.
Mar 14, 2019 04:01 pm ET
Catasys Reports 2018 Fourth Quarter and Year-end Financial Results
Catasys, Inc. (NASDAQ: CATS), a leading AI and technology-enabled
healthcare company, today reported its financial results for the fourth
quarter and year ended December 31, 2018. The Company provides big
data-based analytics and predictive modeling driven healthcare services
to health plans and their members through its OnTrak™ solution.
Mar 14, 2019 08:30 am ET
Catasys Announces Expansion of Debt Financing Agreement to $15 Million; Proceeds to be Utilized to Support Accelerating Growth
Catasys, Inc. (NASDAQ: CATS), a leading AI and technology-enabled
healthcare company, announced today that it has entered into an
amendment and expansion of its previously announced financing of a
receivable facility agreement and term loan (see:
Mar 13, 2019 08:30 am ET
Catasys to Present at Upcoming Investor Conferences
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, today announced
that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to
participate in two upcoming investor conferences in March, including the
31st Annual ROTH Conference in Laguna Niguel, California and
the Oppenheimer 29th Annual Healthcare Conference in New York
City. Management will hold one-on-one meetings with investors during the
conferences.
Mar 12, 2019 08:30 am ET
Catasys Schedules Fourth Quarter 2018 Results Conference Call for March 14, 2019
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, today announced
that the Company will be releasing financial results for its fourth
quarter and year ended December 31, 2018, after the closing of the stock
market on Thursday, March 14, 2019.
Feb 26, 2019 08:30 am ET
Sharps Compliance Adds Sharon R. Gabrielson, Chair of Mayo Clinic’s Global Business Solutions, to Board of Directors
Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced the appointment of Sharon R....
Nov 14, 2018 04:05 pm ET
Catasys Reports 2018 Third Quarter Financial Results
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today reported its financial
results for the third quarter ended September 30, 2018. The Company
provides big data-based analytics and predictive-modeling-driven
healthcare services to health plans and their members through its
OnTrak™ solution.
Nov 13, 2018 08:30 am ET
Catasys to Announce Third Quarter 2018 Results and Host Conference Call on November 14, 2018
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, today announced
that the Company will be releasing financial results for its third
quarter and nine months ended September 30, 2018, after the closing of
the stock market on Wednesday, November 14, 2018.
Nov 01, 2018 08:30 am ET
Catasys Appoints Three Healthcare Executives to Board of Directors
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced the
appointment of Edward Zecchini, Sharon Gabrielson, and Diane Seloff to
its Board of Directors. Messrs. Rick Anderson and Dave Smith have
stepped down as directors to accommodate the new Board members. With
these changes, Catasys has a total of seven Board members.
Oct 31, 2018 08:30 am ET
Catasys Announces Signing of Agreement with Capital BlueCross
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it has
entered into an agreement with Capital BlueCross, a community-based
health insurer serving members in 21 counties in Central Pennsylvania
and the Lehigh Valley. Beginning the first quarter of 2019, eligible
Capital BlueCross commercial members will be able to take advantage of
Catasys’ OnTrak solution, an integrated 52-week program that identifies,
engages and treats members with untreated behavioral heal
Oct 02, 2018 08:30 am ET
Catasys Chief Medical Officer to Present Keynote Address at the 2018 Zarrow Mental Health Symposium: Innovations in Mental Health
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that its
Chief Medical Officer Dr. Omar Manejwala is expected to deliver a
keynote address at the 2018 Zarrow Mental Health Symposium. His address,
titled “Addiction: A Futurist’s Perspective,” is scheduled to take place
at 8:30 am CT on Friday, October 5, 2018, at the Cox Business Center in
Tulsa, Oklahoma.
Sep 27, 2018 08:30 am ET
Catasys Calls for Improved Engagement to Solve for the Crisis of Untreated Anxiety Disorders in Published Paper Authored by Chief Medical Officer
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that a paper
authored by its Senior Vice President and Chief Medical Officer Omar S.
Manejwala titled “Anxiety
Disorders: Scope and Clinical
Sep 25, 2018 08:30 am ET
Catasys Announces Expansion of OnTrak-A Solution to Florida and Georgia with Leading National Health Plan
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it has
expanded its OnTrak-A solution into Florida and Georgia with one of the
nation’s leading health plans. This follows OnTrak-A’s expansion into
Iowa and Nebraska earlier this month.
Sep 12, 2018 08:00 am ET
Catasys Expands OnTrak-A Solution to Iowa and Nebraska with Leading National Health Plan
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today announced that it has
expanded its OnTrak-A solution into Iowa and Nebraska with one of the
nation’s leading health plans, which is the second largest plan in both
states.
Aug 14, 2018 04:01 pm ET
Catasys Reports 2018 Second Quarter Financial Results
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI
and technology-enabled healthcare company, today reported its financial
results for the second quarter ended June 30, 2018. The Company provides
big data-based analytics and predictive-modeling-driven healthcare
services to health plans and their members through its OnTrak™ solution.
Aug 13, 2018 08:00 am ET
Catasys to Announce Second Quarter 2018 Results and Host Conference Call on August 14, 2018
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, today announced
that the Company will be releasing financial results for its second
quarter and six months ended June 30, 2018, after the closing of the
stock market on Tuesday, August 14, 2018.
Aug 02, 2018 07:00 pm ET
CORRECTING and REPLACING Catasys to Present at the Canaccord Genuity 38th Annual Growth Conference
Headline of release dated August 1, 2018, should read: Catasys to
Present at the Canaccord Genuity 38th Annual Growth
Conference (instead of Catasys to Present at the Cannacord Genuity 38th
Annual Growth Conference). Also, the first paragraph, first sentence
should read: Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the
“Company”), a leading AI and technology-enabled healthcare company,
today announced that Mr. Terren Peizer, the Company’s Chairman and CEO,
and Mr. Christopher Shirley, the Company’s Chief F
Jul 18, 2018 08:00 am ET
Catasys Appoints Industry Veteran Jeremiah Stone to Newly Created Chief Technology Officer Role
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, today announced
Jeremiah Stone’s appointment as the Company’s Chief Technology Officer,
a newly created position within the Company. He will be responsible for
the strategic direction and evolution of Catasys’ global technology
operations, including the predictive analytics and digital technology
behind the Catasys OnTrak program.
Jun 14, 2018 08:00 am ET
Catasys Attracts $10 Million in Debt Financing to Support Accelerating Growth
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a
leading AI and technology-enabled healthcare company, announced today
that it has entered into a $10 million financing comprised of a
receivable facility agreement of $2.5 million with Heritage Bank of
Commerce (“Heritage”) and a four-year term loan of up to $7.5 million
with Horizon Technology Finance Corporation (“Horizon”) (NASDAQ:HRZN).
May 30, 2018 08:00 am ET
Catasys Launches OnTrak Solution with Second Largest Health Plan in the Nation
Catasys, Inc. (NASDAQ:CATS), a leading AI and technology-enabled
healthcare company, announced today that it has entered into an
agreement and launched its OnTrak program with the second largest health
plan in the United States. With this agreement, Catasys is now
contracted with 7 of the top 8 insurers nationwide. Catasys’ OnTrak
program has initially launched with this plan in California, which
brings the number of states in which OnTrak is available to 20.
May 15, 2018 04:01 pm ET
Catasys Reports 2018 First Quarter Financial Results
Catasys, Inc. (NASDAQ:CATS), a leading AI and technology-enabled
healthcare company, today reported its financial results for the first
quarter ended March 31, 2018. The Company provides big data-based
analytics and predictive-modeling-driven healthcare services to health
plans and their members through its OnTrak™ solution.
May 14, 2018 08:00 am ET
Catasys to Announce First Quarter 2018 Results and Host Conference Call on May 15, 2018
Catasys, Inc. (NASDAQ:CATS), a leading AI and technology-enabled
healthcare company, announced that the Company will be releasing
financial results for its first quarter ended March 31, 2018, after the
closing of the stock market on Tuesday, May 15, 2018.
Apr 18, 2018 11:23 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Catasys, Inc.
Levi & Korsinsky announces it has commenced an investigation of Catasys,
Inc. (NASDAQCM:CATS) concerning possible breaches of fiduciary duty. To
obtain additional information, go to:
Apr 12, 2018 08:00 am ET
Catasys Chief Medical Officer Dr. Omar Manejwala To Present at the National Council for Behavioral Health Conference
Catasys, Inc. (NASDAQ:CATS), a leading AI and technology-enabled
healthcare company, announced today that the Company’s Senior Vice
President and Chief Medical Officer, Omar Manejwala, M.D., will be
presenting at the nation’s largest behavioral health event, the National
Council for Behavioral Health Conference on Tuesday, April 24, 2018 at
The Gaylord National Resort and Convention Center, Maryland.
Mar 14, 2018 08:00 am ET
Catasys Launches Enrollment of OnTrak-H with Leading National Health Insurer
Catasys, Inc. (NASDAQ:CATS), a leading AI and
technology-enabled healthcare company, announced today that it has
launched enrollment of its OnTrak-H solution with a leading national
health plan partner. Eligible Commercial members in 16 states will now
be able to take advantage of OnTrak-H, an integrated 52-week program
that identifies, engages and treats members with untreated behavioral
health conditions and high medical costs. OnTrak-H specifically
addresses substance use disorders. Effectively engaging and treating
membe
Mar 07, 2018 04:05 pm ET
Catasys Reports 2017 Fourth Quarter and Year-end Financial Results
Catasys, Inc. (NASDAQ: CATS), a leading AI and technology-enabled
healthcare company, today reported its financial results for the fourth
quarter and year ended December 31, 2017. The Company provides big
data-based analytics and predictive modeling driven healthcare services
to health plans and their members through its OnTrak™ solution.
Mar 07, 2018 08:00 am ET
Catasys to Announce Fourth Quarter and Year-end 2017 Results and Host Conference Call at 4:30 pm ET This Afternoon
Catasys, Inc. (NASDAQ:CATS), a leading AI and technology-enabled
healthcare company, announced that the Company will be releasing
financial results for its fourth quarter and year ended December 31,
2017, after the closing of the stock market this afternoon (Wednesday,
March 7, 2018).
Mar 06, 2018 08:00 am ET
Catasys Announces Expansion of OnTrak-HA
Catasys, Inc. (NASDAQ:CATS) a leading AI and technology-enabled
healthcare company, announced today that it has expanded the OnTrak-HA
program with a leading regional health insurer in Illinois to include
anxiety and depression for eligible commercial and Medicare members.
Prior to this expansion, OnTrak-HA covered eligible commercial and
Medicare members with substance use disorders and eligible individual
and public marketplace plan members with anxiety, depression and
substance use disorders. This expansion is based on the success of the
Feb 23, 2018 08:00 am ET
Catasys to Announce Fourth Quarter and Year-End 2017 Results and Host Conference Call on March 7, 2018
Catasys, Inc. (NASDAQ: CATS), a leading AI and technology-enabled
healthcare company, announced that the Company will be releasing
financial results for its fourth quarter and year ended December 31,
2017, after the closing of the stock market on Wednesday, March 7, 2018.
Feb 21, 2018 08:00 am ET
Catasys Announces Launch of Enrollment with National Health Insurer
Catasys, Inc. (NASDAQ: CATS), a leading AI and technology-enabled
healthcare company, announced today that it has commenced enrollment for
the OnTrak-Ci program under the previously announced contract with a top
10 health insurer. The program is starting with eligible Medicare
Advantage members in Tennessee who suffer from anxiety, depression and
substance use disorders, and represents the second national plan that
has partnered with Catasys in the state of Tennessee. Enrollment is
expected to ramp throughout 2018.
Jan 31, 2018 08:00 am ET
Catasys Announces Expansion of OnTrak-HC to Illinois with Second Largest Blue Cross Blue Shield Health Plan
Catasys (NASDAQ:CATS), a leading AI and technology-enabled healthcare
company, announced today that it has expanded the OnTrak-HC program to
Illinois with the nation’s second largest Blue Cross Blue Shield health
insurance plan. This company is the country's largest nonpublic health
insurer and the fourth-largest health insurer overall, with health plans
also in Texas, Oklahoma, New Mexico and Montana. This expansion follows
the successful OnTrak-HC launch in Oklahoma in August, 2017.
Jan 24, 2018 08:00 am ET
Catasys OnTrak Program Delivers 54% Savings for Health Plans
Catasys, Inc. (NASDAQ:CATS), which harnesses proprietary big data
predictive analytics, artificial intelligence and telehealth, combined
with human engagement, to deliver improved member health and cost
savings to health plans through integrated technology enabled treatment
solutions, today announced that its OnTrak program has reduced costs for
enrolled members by an average of 54%, or $1,338 per member per month
(PMPM). These savings were primarily driven by declines in inpatient
hospital admissions and emergency room visits. Prior to e
Jan 16, 2018 08:00 am ET
Catasys Announces Agreement with Cigna
Catasys, Inc. (NASDAQ:CATS), a provider of proprietary predictive
analytics and integrated treatment solutions to health plans, today
announced that it has entered into an agreement with Cigna Corporation
(NYSE:CI), a global health service company dedicated to helping people
improve their health, well-being and sense of security, for Catasys’
OnTrak solution for certain members with anxiety, depression or
substance use disorders. The first market is expected to launch in the
first quarter of 2018.
Nov 14, 2017 04:02 pm ET
Catasys Reports 2017 Third Quarter Financial Results
Catasys, Inc. (NASDAQ: CATS), a provider of proprietary
predictive analytics and integrated treatment solutions to health plans,
today reported its financial results for the third quarter and nine
months ended September 30, 2017. The Company provides big data based
analytics and predictive modeling driven behavioral healthcare services
to health plans and their members through its OnTrak™ solution.
Nov 14, 2017 08:30 am ET
Catasys to Announce Third Quarter 2017 Results After Close of Market and Host Conference Call at 4:30 PM ET This Afternoon
Catasys, Inc. (NASDAQ:CATS), a provider of proprietary predictive
analytics and integrated treatment solutions to health plans, announced
that the Company will be releasing its third quarter ended September 30,
2017 financial results after the closing of the stock market this
afternoon (Tuesday, November 14th, 2017).
Oct 30, 2017 08:30 am ET
Catasys Cites Need for Integrated Solution to Treat Behavioral Health Disorders Following President Trump’s Declaration of Opioid Epidemic
Catasys, Inc. (NASDAQ:CATS), a provider of proprietary predictive
analytics and integrated treatment solutions to health plans, today
announced that it concurs with the Trump administration’s decision to
declare the opioid epidemic an emergency but noted that further action
is desperately needed.
Oct 25, 2017 08:30 am ET
Catasys to Announce Third Quarter 2017 Results and Host Conference Call on Tuesday, November 14th, 2017
Catasys, Inc. (NASDAQ: CATS), a provider of proprietary
predictive analytics and integrated treatment solutions to health plans,
announced that the Company will be releasing its third quarter ended
September 30, 2017 financial results after the closing of the stock
market on Tuesday, November 14th, 2017.
Oct 18, 2017 09:30 am ET
Taglich Brothers Initiates Coverage of Catasys, Inc.
Taglich Brothers, Inc. announces it has initiated coverage of Catasys, Inc. (NASDAQ: CATS).Catasys, headquartered in Los Angeles, California, provides specialized behavioral health management and integrated treatment services to health plans through...
Jun 01, 2017 09:00 am ET
Catasys to Increase Enrollment for OnTrak-A in Eight States with Leading National Health Insurance Plan
LOS ANGELES, June 1, 2017 /PRNewswire/ --
May 24, 2017 09:30 am ET
Catasys Begins Enrollment for OnTrak-C Solution in Texas with Leading National Health Insurance Provider
LOS ANGELES, May 24, 2017 /PRNewswire/ --
May 16, 2017 09:30 am ET
Catasys Appoints New Chief Financial Officer
LOS ANGELES, May 16, 2017 /PRNewswire/ -- Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today announced the appointment of Christopher Shirley as its new Chief Financial Officer, effective immediately. Mr. Shirley succeeds Susan Etzel, who was appointed SVP of Finance and will remain a key member of the Company's financial team.
May 15, 2017 07:08 pm ET
Catasys Revenue Increased 150% in the First Quarter of 2017
LOS ANGELES, May 15, 2017 /PRNewswire/ --
May 10, 2017 09:00 am ET
Catasys to Announce First Quarter 2017 Results
LOS ANGELES, May 10, 2017 /PRNewswire/ -- Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it will report its results for the three-month period ended March 31, 2017, after the market close on Monday, May 15, 2017.
May 01, 2017 09:00 am ET
Catasys Further Strengthens Balance Sheet with Conversion of all Debt into Common Stock
LOS ANGELES, May 1, 2017 /PRNewswire/ -- Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it has strengthened its balance sheet with the conversion of its outstanding convertible debt and deferred compensation.
Apr 28, 2017 05:05 pm ET
Catasys Announces Closing of $15 Million Public Offering
LOS ANGELES, April 28, 2017 /PRNewswire/ -- Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today announced the closing of its previously announced underwritten public offering of 3,125,000 shares of common stock. The shares were listed on the Nasdaq Capital Market under the symbol CATS on April 26, 2017.
Apr 27, 2017 09:30 am ET
Catasys to Participate in Joseph Gunnar's Pioneers 2017 Conference on May 2
LOS ANGELES, April 27, 2017 /PRNewswire/ -- Catasys, Inc. (NasdaqCM: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that Terren Peizer, Chairman of the Board and Chief Executive Officer, will present at Joseph Gunnar's Pioneers 2017 Conference to be held at the Mandarin Oriental Hotel in New York City on Tuesday, May 2, 2017 at 10:00 am ET.
Apr 26, 2017 05:35 pm ET
Catasys to Present at RedChip's Global Online Growth Conference on April 27
LOS ANGELES, April 26, 2017 /PRNewswire/ -- Catasys, Inc. (NasdaqCM: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that Terren Peizer, Chairman of the Board and Chief Executive Officer, will present at RedChip's Global Online Growth Conference on Thursday, April 27, 2017 at 3:00 p.m. ET. The presentation can be viewed at www.RedChip.com. A live Q&A session will follow the investor presentation.
Apr 25, 2017 10:22 pm ET
Catasys Announces $15 Million Public Offering and NASDAQ Listing
LOS ANGELES, April 25, 2017 /PRNewswire/ -- Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today announced the pricing of an underwritten public offering of 3,125,000 shares of common stock at a public offering price of $4.80 per share. The shares of common stock have been approved to list on the Nasdaq Capital Market under the symbol "CATS" and are scheduled to begin trading on NASDAQ on April 26, 2017.
Apr 24, 2017 09:30 am ET
Catasys Contracts with Second Largest Blue Cross Blue Shield
LOS ANGELES, April 24, 2017 /PRNewswire/ --
Mar 21, 2017 09:30 am ET
Catasys Expands Coverage of OnTrak-C Solution to Texas with Leading National Health Insurance Provider
LOS ANGELES, March 21, 2017 /PRNewswire/ --
Mar 08, 2017 08:30 am ET
Catasys and Health Alliance Medical Plans Announce Expansion of OnTrak
LOS ANGELES, March 8, 2017 /PRNewswire/ --
Mar 02, 2017 08:30 am ET
Catasys to Participate in the 29th Annual ROTH Conference on March 15, 2017
LOS ANGELES, March 2, 2017 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that Terren Peizer, Chairman of the Board and Chief Executive Officer, will present at the 29th Annual ROTH Conference to be held at The Ritz-Carlton, Laguna Niguel in Dana Point, CA on Wednesday, March 15, 2017 at 8:30 am PT / 11:30 am ET.
Mar 01, 2017 08:30 am ET
Catasys Reports Revenue Increase of 200% to $3.8 million for the Fourth Quarter of 2016
- Generated Positive EBITDA in Fourth Quarter 2016
Feb 16, 2017 08:30 am ET
Catasys Expands OnTrak-A Solution to Massachusetts with Leading National Health Insurance Provider
LOS ANGELES, Feb. 16, 2017 /PRNewswire/ -- Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it has entered into an agreement to expand its OnTrak™-A solution with one of the nation's leading health plans to Massachusetts. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Feb 02, 2017 08:30 am ET
Catasys Contracts with the Largest U.S. Health Insurance Company
- OnTrak-U Solution initially launching in 8 states
Feb 01, 2017 08:30 am ET
Catasys to Host Investor Call on February 2, 2017
LOS ANGELES, Feb. 1, 2017 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary predictive analytics and integrated treatment solutions for anxiety, depression and substance use disorders to health plans, announced today that it will host a call on Thursday, February 2, 2017 at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time, during which Terren Peizer, Chairman of the Board and Chief Executive Officer, and Rick Anderson, President and Chief Operating Officer, will update investors on Catasys' operations.
Dec 16, 2016 02:48 pm ET
Catasys, Inc. Issues Letter to Shareholders
LOS ANGELES, Dec. 15, 2016 /PRNewswire/ --
Dec 13, 2016 08:30 am ET
Catasys Expands Coverage of OnTrak Solution with an Existing Health Plan Customer in Illinois
LOS ANGELES, Dec. 13, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS) a provider of proprietary predictive analytics and integrated treatment solutions for anxiety, depression and substance use disorders to health plans, announced today that an existing health plan customer will expand the OnTrak™ solution to include its eligible individual market and health insurance exchange members in Illinois for all three disease states, including depression, anxiety and substance use disorders. Catasys already provides its OnTrak solution to the health plan's eligible commercial and Medicare members.
Nov 15, 2016 08:30 am ET
Catasys Reports Third Quarter 2016 Financial Results
LOS ANGELES, Nov. 15, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling and integrated treatment solutions for anxiety, depression and substance use disorders to health plans, today reported financial results for the third quarter ended September 30, 2016.
Sep 20, 2016 11:56 am ET
Catasys to Participate in Aegis Capital 2016 Annual Growth Conference on September 22, 2016
LOS ANGELES, Sept. 20, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling and integrated treatment programs for substance dependence, depression and anxiety on behalf of health plans, announced today that Terren Peizer, Chairman of the Board and Chief Executive Officer, will present at the Aegis Capital 2016 Annual Growth Conference to be held at The Encore Hotel in Las Vegas on Thursday, September 22, 2016 at 10:00 am PT.
Aug 16, 2016 09:00 am ET
Catasys Reports Second Quarter 2016 Financial Results
LOS ANGELES, Aug. 16, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling and integrated treatment programs for substance dependence, depression and anxiety on behalf of health plans, today reported financial results for the second quarter ended June 30, 2016.
Jul 27, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Florida with Leading National Health Insurance Provider
LOS ANGELES, July 27, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has extended its OnTrak™-H solution in Florida to Medicare Advantage members with one of the nation's leading health plans. With the addition of Medicare members to this plan's existing program means their eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psycho
Jul 20, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in North Carolina with Leading National Health Insurance Provider
LOS ANGELES, July 20, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in North Carolina with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jul 13, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Georgia with Leading National Health Insurance Provider
LOS ANGELES, July 13, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Georgia with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jul 06, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Virginia with Leading National Health Insurance Provider
LOS ANGELES, July 6, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Virginia with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jun 28, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in South Carolina with Leading National Health Insurance Provider
LOS ANGELES, June 28, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in South Carolina with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jun 22, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Tennessee with Leading National Health Insurance Provider
LOS ANGELES, June 22, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Tennessee with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jun 07, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-A Solution in Oklahoma with Leading National Health Insurance Provider
LOS ANGELES, June 7, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-A solution in Oklahoma with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jun 01, 2016 09:30 am ET
Catasys to Participate in LD Micro Invitational on June 7, 2016
LOS ANGELES, June 1, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that Terren Peizer, Chairman of the Board and CEO, will present at the LD Micro Invitational to be held at the Luxe Sunset Bel Air in Los Angeles on Tuesday, June 7, 2016 at 12:00 pm PT.
May 18, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Texas with Leading National Health Insurance Provider
LOS ANGELES, May 18, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Texas with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
May 16, 2016 09:30 am ET
Catasys Reports First Quarter 2016 Financial Results
LOS ANGELES, May 16, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling based behavioral health management services for health plans, today reported financial results for the first quarter ended March 31, 2016.
Apr 28, 2016 09:30 am ET
Catasys to Participate in Joseph Gunnar's Pioneers 2016 Conference on May 5, 2016
LOS ANGELES, April 28, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that Terren Peizer, Chairman of the Board and CEO, will present at Joseph Gunnar's Pioneers 2016 Conference to be held at the New York Palace Hotel in New York City on Thursday, May 5, 2016 at 2:00 pm ET.
Apr 18, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Louisiana with Leading National Health Insurance Provider
LOS ANGELES, April 18, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Louisiana with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Mar 31, 2016 09:30 am ET
Catasys Reports Full Year 2015 Financial Results
LOS ANGELES, March 31, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling based behavioral health management services for health plans, today reported financial results for the full year ended December 31, 2015.
Mar 24, 2016 09:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Illinois with Leading National Health Insurance Provider
LOS ANGELES, March 24, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Illinois with one of the nation's leading health plans. The plan's eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Mar 18, 2016 10:44 am ET
Catasys Expands Rollout of OnTrak-H Solution in Oklahoma with Leading National Health Insurance Provider
LOS ANGELES, March 18, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Oklahoma with one of the nation's leading health plans. The plan's eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Mar 10, 2016 08:30 am ET
Catasys Expands Rollout of OnTrak-H Solution in Pennsylvania with Leading National Health Insurance Provider
LOS ANGELES, March 10, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Pennsylvania with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Mar 08, 2016 10:06 am ET
Catasys Expands Rollout of OnTrak-A Solution into Illinois with Leading National Health Insurance Provider
LOS ANGELES, March 8, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-A solution in Illinois with one of the nation's leading health plans. The plan's eligible commercial members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Feb 24, 2016 08:30 am ET
Catasys Expands Rollout of OnTrak-H Solution into Missouri with Leading National Health Insurance Provider
LOS ANGELES, Feb. 24, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Missouri with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Feb 18, 2016 08:30 am ET
Catasys Expands Rollout of OnTrak-H Solution into Kansas with Leading National Health Insurance Provider
LOS ANGELES, Feb. 18, 2016 /PRNewswire/ -- Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution in Kansas with one of the nation's leading health plans. The plan's eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.
Jan 20, 2016 10:37 am ET
/C O R R E C T I O N -- Catasys, Inc./
In the news release, Catasys Expands Rollout of OnTrak-H Solution into Wisconsin with Leading National Health Insurance Provider, issued Jan. 20, 2016 by Catasys, Inc. over PR Newswire, we are advised by the company that there has been an update to the text. The complete, corrected release follows:
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.